Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 6/20 | 0.35 |
| ▸ | CDK2 | P24941 | 5/20 | 0.34 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.34 |
| ▸ | CCNA1 | P78396 | 4/20 | 0.34 |
| ▸ | AURKA | O14965 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.32 |
| ▸ | CDK4 | P11802 | 1/20 | 0.32 |
| ▸ | CCND3 | P30281 | 1/20 | 0.32 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.32 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.32 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.32 |
| ▸ | GRK2 | P25098 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6793189 | 0.86 | CDK2 (0.35) | ROCK2CDK2CCNA2CCNA1AURKA | |
| SCHEMBL6794173 | 0.85 | ROCK2 (0.38) | ROCK2CDK2CCNA2CCNA1AURKA | |
| SCHEMBL6795982 | 0.81 | CDK2 (0.45) | ROCK2CDK2CCNA2CCNA1AURKA | |
| SCHEMBL1659385 | 0.80 | CDK2 (0.34) | ROCK2CDK2CCNA2CCNA1AURKA | |
| Hydrochloric Acid SCHEMBL6793245 | 0.79 | CCNA2 (0.37) | CDK2CCNA2CCNA1KDM4EALDH1A1 | |
| SCHEMBL6793304 | 0.79 | KDM4C (0.37) | CDK2CCNA2CCNA1AURKAAAK1 | |
| SCHEMBL6794272 | 0.79 | CCNA2 (0.37) | CDK2CCNA2CCNA1KDM4ECDK4 | |
| Hydrochloric Acid SCHEMBL6789049 | 0.78 | CDK2 (0.37) | CDK2CCNA2CCNA1KDM4EALDH1A1 | |
| SCHEMBL6792409 | 0.78 | TEAD2 (0.38) | CDK2CCNA2CCNA1KDM4EALDH1A1 | |
| SCHEMBL1655455 | 0.76 | CDK2 (0.36) | ROCK2CDK2CCNA2CCNA1AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | PHARMACIA CORPORATION | 2004-07-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | MKNK2, MAPKAPK2, MAP3K2 | ROCK2 317/4885CDK2 29/4885CCNA2 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.